Becton, Dickinson and Stock Forecast for 2023 - 2025 - 2030

Updated on 04/01/2023

Stock Rating
17
Price Target
$275.00
Consensus
Outperform
Upside
11.12%
Analysts
12
Stock Rating
17
Upside
11.12%
Analysts
12
Price Target
$275.00

Becton, Dickinson and Stock Forecast and Price Target

Given the average yearlong price target of $275.00 provided by twelve prominent analysts over the past few months, there is a potential upside of approximately 11.12% from the last closing price in March, 2023 for Becton, Dickinson and's stock if it is reached. This estimation is based on a high estimate of $306.00 and a low estimate of $245.00. If you're interested in BDX stock, looking at its competitors might also be a good idea.

$275.00

11.12% Upside

Outperform
Outperform

Becton, Dickinson and Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's Price has decreased by 2.83%, from $250.65 to $243.57. For next year, analysts predict Fair Value of $268.68, which would mean an increase of 10.31%. Over the next eight years, experts predict that Becton, Dickinson and's Fair Value will grow at a rate of 46.04%.

2023 Fair Value Forecast
$268.68
2024 Fair Value Forecast
$298.72
2025 Fair Value Forecast
$343.36
2026 Fair Value Forecast
$374.26
2027 Fair Value Forecast
$372.97
2028 Fair Value Forecast
$346.98
2029 Fair Value Forecast
$346.49
2030 Fair Value Forecast
$355.71
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 10
$154.95 $181.05 16.49%
LLY Stock Forecast Eli Lilly and Outperform 16
$343.42 $333.19 16.48%
ABBV Stock Forecast AbbVie Outperform 10
$159.36 $162.24 3.54%
AVGO Stock Forecast Broadcom Outperform 9
$641.35 $656.43 2.75%
AZN Stock Forecast AstraZeneca PLC Outperform 8
£11.25k £153.20 -98.61%

Becton, Dickinson and Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's Revenue has grown by 9.14%, rising from $17.29B to $18.87B. For next year, analysts predict Revenue of $19.46B, which would mean an increase of 3.11%. Over the next eight years, experts predict that Becton, Dickinson and's Revenue will grow at a rate of 17.97%.

2023 Rev Forecast
$19.46B
2024 Rev Forecast
$20.49B
2025 Rev Forecast
$21.35B
2026 Rev Forecast
$22.41B
2027 Rev Forecast
$23.63B
2028 Rev Forecast
$22.53B
2029 Rev Forecast
$22.16B
2030 Rev Forecast
$22.26B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ABT Stock Forecast Abbott Laboratories Outperform 10
$101.26 $121.44 23.44%
DHR Stock Forecast Danaher Corp Outperform 10
$252.04 $304.24 20.81%
ISRG Stock Forecast Intuitive Surgical Inc Outperform 15
$255.47 $273.80 10.38%

Becton, Dickinson and Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's Dividend per Share has grown, rising from $3.08 to $3.48 – a growth of 12.99%. In the next year, analysts believe that Dividend per Share will reach $4.06 – an increase of 16.67%. For the next eight years, the forecast is for Dividend per Share to grow by 33.87%.

2023 DPS Forecast
$4.06
2024 DPS Forecast
$4.94
2025 DPS Forecast
$4.36
2026 DPS Forecast
$4.58
2027 DPS Forecast
$4.81
2028 DPS Forecast
$4.87
2029 DPS Forecast
$4.69
2030 DPS Forecast
$4.66
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
GE Stock Forecast General Electric Outperform 9
$95.60 $86.47 -9.00%
GSK Stock Forecast GSK Hold 16
£1.43k £16.95 -98.87%
BSX Stock Forecast Boston Scientific Outperform 15
$50.03 $52.51 -0.06%

Becton, Dickinson and Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's Free Cash Flow has seen a drop from $2.37B to $1.80B – a 24.32% decrease. In the next year, analysts believe that Free Cash Flow will reach $3.26B – an increase of 81.51%. For the next eight years, the forecast is for Free Cash Flow to grow by 133.55%.

2023 FCF Forecast
$3.26B
2024 FCF Forecast
$3.50B
2025 FCF Forecast
$3.90B
2026 FCF Forecast
$4.35B
2027 FCF Forecast
$4.58B
2028 FCF Forecast
$4.19B
2029 FCF Forecast
$4.11B
2030 FCF Forecast
$4.19B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
EMR Stock Forecast Emerson Electric Outperform 10
$87.09 $104.16 20.56%
BAYN Stock Forecast Bayer Outperform 7
58.72€ 74.54€ 28.58%
6501 Stock Forecast Hitachi Buy 18
¥6.56k ¥0.00 29.65%

Becton, Dickinson and Net Income Forecast for 2023 - 2025 - 2030

Becton, Dickinson and's Net Income has grown In the last three years, rising from $1.23B to $1.78B – a growth of 44.28%. In the next year, analysts believe that Net Income will reach $3.56B – an increase of 100.27%. For the next eight years, experts predict that Becton, Dickinson and's Net Income will grow at a rate of 157.18%.

2023 NI Forecast
$3.56B
2024 NI Forecast
$3.89B
2025 NI Forecast
$4.26B
2026 NI Forecast
$4.72B
2027 NI Forecast
$4.99B
2028 NI Forecast
$4.59B
2029 NI Forecast
$4.49B
2030 NI Forecast
$4.58B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
A Stock Forecast Agilent Technologies Outperform 17
$138.34 $162.50 20.36%
ECL Stock Forecast Ecolab Inc Outperform 18
$165.52 $164.25 -0.31%
LONN Stock Forecast Lonza Group Ltd Outperform 16
CHF457.90 CHF756.46 71.98%

Becton, Dickinson and EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's EBITDA has gone down from $5.20B to $4.85B – a 6.68% drop. For the next year, analysts predict that EBITDA will reach $5.40B – an increase of 11.30%. Over the next eight years, experts believe that Becton, Dickinson and's EBITDA will grow at a rate of 36.55%.

2023 EBITDA Forecast
$5.40B
2024 EBITDA Forecast
$5.98B
2025 EBITDA Forecast
$6.45B
2026 EBITDA Forecast
$7.01B
2027 EBITDA Forecast
$6.62B
2028 EBITDA Forecast
$6.41B
2029 EBITDA Forecast
$6.44B
2030 EBITDA Forecast
$6.62B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
ALC Stock Forecast Alcon Outperform 15
CHF66.18 CHF0.00 30.51%
ILMN Stock Forecast Illumina Inc Outperform 16
$232.55 $254.08 7.29%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.92k ¥0.00 24.74%

Becton, Dickinson and EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's EBIT has fallen from $2.94B to $2.62B – a 10.97% decrease. In the next year, analysts predict that EBIT will jump to $4.47B – up 70.70% from the current level. Looking ahead to eight years, experts forecast that EBIT will grow by 120.28%.

2023 EBIT Forecast
$4.47B
2024 EBIT Forecast
$4.88B
2025 EBIT Forecast
$5.50B
2026 EBIT Forecast
$5.96B
2027 EBIT Forecast
$6.22B
2028 EBIT Forecast
$5.74B
2029 EBIT Forecast
$5.67B
2030 EBIT Forecast
$5.77B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
COLO B Stock Forecast Coloplast A/S Hold 18
kr848.20 kr1.05k 21.43%
BAX Stock Forecast Baxter International Inc Outperform 17
$40.56 $60.73 43.00%
7751 Stock Forecast Canon Hold 18
¥2.86k ¥0.00 16.95%

Becton, Dickinson and EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Becton, Dickinson and's EPS has decreased by 2.83%, from $11.68 to $11.35. For next year, analysts predict EPS of $12.52, which would mean an increase of 10.31%. Over the next eight years, experts predict that Becton, Dickinson and's EPS will grow at a rate of 46.04%.

2023 EPS Forecast
$12.52
2024 EPS Forecast
$13.92
2025 EPS Forecast
$16.00
2026 EPS Forecast
$17.44
2027 EPS Forecast
$17.38
2028 EPS Forecast
$16.17
2029 EPS Forecast
$16.15
2030 EPS Forecast
$16.58
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
LH Stock Forecast Laboratory Corp of America Hol... Outperform 11
$229.42 $278.38 19.87%
FRE Stock Forecast Fresenius SE & Co. KGaA Outperform 18
24.85€ 35.23€ 30.78%
HOLX Stock Forecast Hologic Inc Outperform 8
$80.69 $79.86 2.24%